(P604) Integration of Glycemic Management Indicator into the EHR: A Diabetes-Cardiometabolic Digital Health App

Cardiometabolic digital health solutions, which address conditions like diabetes, are increasingly being integrated into clinical care. These solutions can provide personalized, AI-driven self-management support for individuals living with chronic conditions and treatment insights to inform timely therapy optimization for clinicians. The Allina Health System (Minneapolis, MN) has successfully integrated an FDA-cleared cardiometabolic digital app, Welldoc, focused on diabetes that syncs with continuous glucose monitoring (CGM) devices. The glucose management indicator, or GMI, is an equation used to estimate HbA1c based on CGM mean glucose. Significant enhancements to HEDIS (Healthcare Effectiveness Data and Information Set) Quality Measures for 2025 Glycemic Status added Glucose Management Indicator (GMI) as an alternative to A1C as a measure of glucose management over 3 months. GMI, often called the digital A1C, is calculated from the average CGM glucose. It provides a unique value in that it can be reported in a shorter period, 10-14 days, and allows for faster observation of glucose changes. A1C is the measure of how much glucose has attached to the hemoglobin in the red blood cells over the life of each red blood cell and can be influenced by medical conditions such as anemia that impact the red blood cell. The incorporation of GMI as a quality metric recognizes the value of CGM metrics in assessing diabetes status. Achieving quality metrics is essential to maintaining high Health Plan Ratings and Star ratings for value-based care. This poster describes the integration of the CGM metric, GMI, into the Alina health system electronic health record (EHR), for patients enrolled in Welldoc, the FDA-cleared digital health app for type 1 and type 2 diabetes management using CGM. This integration facilitates the capture of a key quality metric for the health system.